• UCLA Health
  • myUCLAhealth
  • School of Medicine
U Magazine

U Magazine

U Magazine
  • Home
  • Current Issue
  • Centennial Campaign for UCLA Issue
  • Browse U Magazine
  • Letters to the Editor
  • Subscribe
  • Contact
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

U Magazine

Browse U Magazine

  1. Home
  2. Browse U Magazine
Share this
The Cutting Edge

Patient First to Bridge from Experimental Total Artificial Heart to Transplant

  SynCardia Total Artificial Heart
  Human Heart
  The SynCardia Total Artificial Heart (top) and
a human heart (bottom).
Image: Courtesy of SynCardia

A petite 44-year-old woman at UCLA was the first patient in the world to receive a successful heart transplant after “bridging” with an experimental Total Artificial Heart designed for smaller patients. The 50cc SynCardia temporary Total Artificial Heart is a smaller investigational version of the larger 70cc SynCardia heart, which was approved by the Food and Drug Administration (FDA) in 2004 for use in people awaiting a transplant, and has been used by more than 1,440 patients worldwide. The 50cc device is designed to be used by smaller patients — including most women, some men and many adolescents — with end-stage biventricular heart failure to provide mechanical support until a donor heart can be found.

Nemah Kahala, a wife and mother of five, was transferred to UCLA in March. She was suffering from restrictive heart muscle disease and in critical condition. Her heart failure was so advanced that repair surgery and other mechanical-assist devices could not help. Kahala was placed on a life-support system called extracorporeal membrane oxygenation, but this only works for about 10 days before a person’s organs begin to deteriorate. With the clock ticking, doctors needed to buy time by replacing Kahala’s failing heart with an artificial heart while she waited for a heart transplant. Her chest cavity was too small for her to receive the larger 70cc artificial heart. However, under a onetime emergency use permitted under FDA guidelines, her doctors were able to implant the experimental 50cc device.

“Mrs. Kahala’s condition was deteriorating so rapidly that she would have not survived while waiting for a transplant,” says Abbas Ardehali, MD (RES ’95, ’97), director of the UCLA Heart and Lung Transplant Program. “We were grateful to have this experimental technology available to save her life and help bridge her to a donor heart.”

Two weeks after the total artificial heart surgery, she was strong enough to be placed on the heart transplant list. After a week of waiting, a donor heart was found. “In addition to the high-tech medicine that kept her alive, Mrs. Kahala and her family have exemplified how a solid support system that includes loved ones and a compassionate medical team practicing what we at UCLA have termed ‘Relational Medicine’ plays an important role in surviving a medical crisis,” says Mario Deng, MD, medical director of the Advanced Heart Failure, Mechanical Circulatory Support and Heart Transplant Program at UCLA.

Kahala was discharged from UCLA on April 18, 2015. She is grateful to be home in Riverside with her family.


Previous
Protein that Helps Suppress Cancer Fades as We Age
Next
UCLA Community Based Learning: Bridging the Transition from Youth to Adulthood


YOU ARE VIEWING

Fall 2015

Fall 2015
E-Brochure
Printable PDF
IN THIS ISSUE
  • We Are the World
  • Camp Leg Power Propels Kids with Cerebral Palsy Forward
  • Portable Finger Probe Measures Liver Function in Potential Donors
  • Stem-cell Therapy Holds Promise for Eliminating HIV Infection
  • REM Sleep Helps Brain Capture Snapshots of Dream Images
  • Germline Cells Shown to be Vulnerable during Pregnancy
  • New Study Opens Window on Mutations in Genetic Architecture of Schizophrenics
  • How Molecular Rules Govern Autoimmune Disorders
  • Predicting Response to Treatment for Obsessive-Compulsive Disorder
  • Why Children’s Recovery Times Vary after Traumatic Brain Injury
  • Potentially Effective Treatment for Meth Addiction
  • Protein that Helps Suppress Cancer Fades as We Age
  • Patient First to Bridge from Experimental Total Artificial Heart to Transplant
  • UCLA Community Based Learning: Bridging the Transition from Youth to Adulthood
  • Get Social
  • The End of Darkness
  • Medicine 2.0
  • White Knight
  • Awards, Honors & Grants
  • In Memoriam
  • Postcard from Malawi
  • In Her Own Words: Lynn L. Huang, MD ’07
  • The Business of Medical Innovation
  • Tribute to a Mentor and Friend
  • Kaleidoscope Ball Highlights Artistic Variety
  • Landmark Gift Paves the Way for Breakthroughs
  • The UCLA Today’s and Tomorrow’s Children’s Fund Names New Awardees
  • Golden Portal Fundraiser Joins Movies, Medicine and Technology
  • Widening the Circle of Giving
  • UCLA Names Landmark New Medical-Education Building Geffen Hall
  • Gifts
  • In Memoriam
  • Good Afternoon, Mrs. Gates
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest
UCLA Health hospitals ranked best hospitals by U.S. News & World Report
  • UCLA Health
  • Find a Doctor
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Subscribe
  • Patient Stories
  • Giving
  • Careers
  • Volunteer
  • International Services
  • Privacy Practices
  • Nondiscrimination
  • Billing
  • Health Plans
  • Emergency
  • Report Broken Links
  • Terms of Use
  • 1-310-825-2631
  • Maps & Directions
  • Contact Us
  • Your Feedback
  • Report Misconduct
  • Get Social
  • Sitemap
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest

Sign in to myUCLAhealth

Learn more about myUCLAhealth